Prosecution Insights
Last updated: October 27, 2026
Application No. 19/005,402

DEVICES, SYSTEMS AND METHODS FOR IMPROVING CONDUCTIVE COMMUNICATION BETWEEN EXTERNAL DEVICES AND IMPLANTABLE MEDICAL DEVICES

Final Rejection §102§103§112
Filed
Dec 30, 2024
Priority
Jan 30, 2024 — provisional 63/626,698
Examiner
EVANISKO, GEORGE ROBERT
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Pacesetter Inc.
OA Round
2 (Final)
70%
Grant Probability
Favorable
3-4
OA Rounds
1y 2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
662 granted / 940 resolved
At TC average
Strong +35% interview lift
Without
With
+34.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
35 currently pending
Career history
992
Total Applications
across all art units

Statute-Specific Performance

§101
6.7%
-33.3% vs TC avg
§103
30.5%
-9.5% vs TC avg
§102
20.8%
-19.2% vs TC avg
§112
33.2%
-6.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 940 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 7/22/26 have been fully considered but they are not persuasive. The argument that Schmidt teaches a very different approach to determine an edge detection threshold may be correct, however Schmidt still reads on the broad claim limitations. Schmidt senses noise signals, such as peaks, to find a noise baseline in order to increase the threshold over that noise baseline (e.g. paras. 93-94, 85, 91, etc.) and starts the sensing of the noise based on an R wave (e.g. para. 86, etc.), not using/during a frame or advertisement sequence. It is also noted that Schmidt does not discuss frames or advertisement sequences, and the claim is an open-ended “comprising” claim and does not preclude determining the noise baseline also from times/signals when there are frames or advertising sequences—i.e. the claims do not state that no signals are used from periods of advertisement sequences or frames to determine the noise baseline. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4, 6-9, 11-12, 14, and 16-19 are rejected under 35 U.S.C. 102a1 as being anticipated by Schmidt et al (2017/0054516). Schmidt discloses the claimed limitations as follows: --a medical device (e.g. figures 1-3, paras. 68-71, etc. where the device can be internal or external) --sense circuitry configured to use a sensing vector of two electrodes (e.g. elements 106, 206, etc.) --a controller to determine a noise baseline (e.g. elements 110, 210, etc.) where the noise baseline is determined (e.g. paras. 107, 93, 85, etc.) and edge detection threshold is set above the noise baseline (e.g. element 505, paras. 107, 93, 85, etc.), and --comparator circuitry by comparing further sensed signals to produce edge detections (e.g. paras. 81, 93, etc.). As to the newly amended claims and arguments about the amended limitation of obtaining a plurality of sensed amplitude values when the sensed signal includes neither an advertisement sequence nor a frame, and determining a noise baseline from the obtained signals, as seen in figure 5, the noise 504 is sensed neither during an advertisement sequence nor a frame (e.g. at element 502/503), or when a frame is not being conductively communicated. It is also noted that: --Schmidt does not discuss frames or advertisement sequences, --Schmidt does sense the amplitude of noise signals (e.g. paras. 91, 93, 85, etc.) and starts the sensing window based on a cardiac R wave (e.g. para. 86, etc.), not using/during a frame or advertisement sequence, and/or -- the claim is an open-ended “comprising” claim and does not preclude determining the noise baseline also from times/signals when there are frames or advertising sequences. For claim(s): 2, decode a message (paras. 12-16, 50, etc.); 3, external MD (e.g. para. 71, with internal device and skin electrodes—note that the dry electrodes have not been positively recited—in the alternative, see the 103 rejection below); 4, amplified and filtered signal to determine the noise baseline (e.g. paras. 81, 107, 93, 85, etc.); 6, as the system senses the peak values of the noise, the noise baseline will be based on the peaks (e.g. paras. 107, 93, 85, etc.); for claim 7 and 17, using a threshold equal to noise baseline plus an offset (e.g. paras. 93-94, 85, etc.; an offset above the peak/maximum values); 8 and 18, as seen in figure 5, the noise 504 is sensed neither during an advertisement sequence, nor a frame (e.g. at element 502/503), or when a frame is not being conductively communicated. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 3, 5, 13, and 15 are rejected under 35 U.S.C. 103 as being unpatentable over Schmidt et al. Schmidt discloses the claimed invention and attachment of the electrodes to the skin, but does not specifically call them dry electrodes, and using the noise signal to find the noise baseline, but not the use of averaging the noise signal for determining the baseline. It would have been obvious to one having ordinary skill in the art at the time the invention was made/before it was effectively filed (and is admitted prior art as the applicant has not specifically pointed out the errors in the examiner’s findings and/or provided evidence of non-obviousness) to have modified the system and method as taught by Schmidt, with the use of dry electrodes on the skin and averaging the noise amplitude values to determine the noise baseline, as is well known and common knowledge in the art, since it would provide the predictable results of allowing faster setup of attachment of the electrodes to the skin without requiring cleanup of gel from gel electrodes and are better for sensitive skin, and providing a better representation of the noise that gets rid of random noise or spikes and that is easier to analyze and determine the value of the noise. Allowable Subject Matter Claims 10 and 20 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to George Robert Evanisko whose telephone number is (571)272-4945. The examiner can normally be reached M-F 8AM-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached at 571-270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /George R Evanisko/Primary Examiner, Art Unit 3792 10/2/26
Read full office action

Prosecution Timeline

Show 1 earlier event
Jun 16, 2026
Non-Final Rejection mailed — §102, §103, §112
Jul 22, 2026
Response Filed
Jul 22, 2026
Examiner Interview Summary
Jul 22, 2026
Applicant Interview (Telephonic)
Oct 06, 2026
Final Rejection mailed — §102, §103, §112
Oct 14, 2026
Interview Requested
Oct 22, 2026
Examiner Interview Summary
Oct 22, 2026
Applicant Interview (Telephonic)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758776
SYSTEMS AND METHODS FOR USING COST PARAMETERS FOR PROGRAMMING ELECTRICAL STIMULATION
3y 8m to grant Granted Oct 13, 2026
Patent 12746396
IMPLANTABLE DEVICE FIXATION MECHANISMS
3y 6m to grant Granted Sep 29, 2026
Patent 12734356
LEAD FOR PACING
1y 8m to grant Granted Sep 15, 2026
Patent 12714869
AUTOMATED EXTERNAL DEFIBRILLATOR SYSTEM
2y 7m to grant Granted Aug 25, 2026
Patent 12708779
SYSTEMS AND METHODS FOR DETECTING ARRHYTHMIAS
3y 8m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
70%
Grant Probability
99%
With Interview (+34.9%)
3y 0m (~1y 2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 940 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month